Inha University Hospital
Incheon, South Korea
NCT Number: NCT02449187
A randomized, open-label, single dose, crossover study to investigate the effect of food on the pharmacokinetics of JLP-1310 in healthy male volunteers.
Looking for future studies?
Notify Me19 year and older
Male
Interventional
Phase 1
Incheon, South Korea
A randomized, open-label, single dose, crossover clinical trial.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In period 1, the subjects will receive an oral pill of JLP-1310 under fasted condition.
In period 2, the subjects will receive an oral pill of JLP-1310 under fed condition.
Other names: metformin hydrochloride, rosuvastatin calcium
In period 1, the subjects will receive an oral pill of JLP-1310 under fed condition.
In period 2, the subjects will receive an oral pill of JLP-1310 under fasted condition.
Other names: metformin hydrochloride, rosuvastatin calcium
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Time frame: 48 hours from baseline
Jeil Pharmaceutical Co., Ltd.
Industry
A Randomized, Open-label, Single Dose, Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00628524
Arterial Occlusive Diseases, Arteriosclerosis
Homburg, Saarland, Germany
View Trial DetailsNCT02029989
Bipolar Disorder, Bipolar and Related Disorders
Duluth, Minnesota, United States
View Trial DetailsNCT03748420
Behavior, Cardiovascular Diseases
Bloomington, Minnesota, United States
View Trial DetailsNCT01142908
Cardiovascular Disease, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial Details